X-26194681-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000379034.1(MAGEB6):c.835G>A(p.Asp279Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000331 in 1,209,304 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000379034.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEB6 | NM_173523.2 | c.835G>A | p.Asp279Asn | missense_variant | 2/2 | ENST00000379034.1 | NP_775794.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEB6 | ENST00000379034.1 | c.835G>A | p.Asp279Asn | missense_variant | 2/2 | 1 | NM_173523.2 | ENSP00000368320.1 |
Frequencies
GnomAD3 genomes AF: 0.00000900 AC: 1AN: 111156Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33344
GnomAD4 exome AF: 0.00000273 AC: 3AN: 1098148Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 1AN XY: 363506
GnomAD4 genome AF: 0.00000900 AC: 1AN: 111156Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2024 | The c.835G>A (p.D279N) alteration is located in exon 2 (coding exon 1) of the MAGEB6 gene. This alteration results from a G to A substitution at nucleotide position 835, causing the aspartic acid (D) at amino acid position 279 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at